智通财经APP讯,MIRXES-B(02629)公布2025年中期业绩,收益为1050万美元,同比增加9.4%。 公司权益股东应占亏损约2835.23万美元,同比收窄36.22%;每股亏损0.185美元。
公告称,收益同比增加主要是由于早期检测及精准多组学分部的 GASTROClearTM及LUNGClearTM产生的收益增加,抵销了因终止FortitudeTM产品销售而导致的传染病分部收益减少260万美元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.